CHEOF vs JNJ: Which Stock is Better?

Side-by-side comparison of Cochlear Limited and Johnson & Johnson in 2026

Comparison Updated:

CHEOF

Cochlear Limited

$125.00

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricCHEOFJNJWinner
Market Cap$11.64B$564.35BJNJ
P/E Ratio47.3421.23JNJ
EPS (TTM)$3.76$11.03JNJ
Revenue Growth-0.0%0.1%JNJ
Gross Margin72.8%68.0%CHEOF

Analyze CHEOF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHEOF or JNJ a better investment?

Comparing CHEOF and JNJ: Cochlear Limited has a market cap of $11.64B while Johnson & Johnson has $564.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHEOF and JNJ?

CHEOF (Cochlear Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHEOF or JNJ?

Based on P/E ratios, JNJ trades at a lower multiple (21.2x vs 47.3x).

Which is growing faster: CHEOF or JNJ?

JNJ has higher revenue growth at 0.1% vs -0.0% for CHEOF.

Which company is more profitable: CHEOF or JNJ?

Cochlear Limited (CHEOF) has higher gross margins at 72.8% compared to 68.0% for JNJ.

Which is the larger company: CHEOF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $564.35B compared to $11.64B for CHEOF.

Should I buy CHEOF or JNJ in 2026?

Both CHEOF and JNJ have investment merit. CHEOF trades at $125.00 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHEOF and JNJ stock?

Key differences: Market Cap ($11.64B vs $564.35B), P/E Ratio (47.3x vs 21.2x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (72.8% vs 68.0%).

Popular Stock Comparisons